TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target

Cancer

Volumn 120, Issue 3, 2014, Pages 352-362

  Da Silva, Sabrina Daniela ^a,b,c   Alaoui Jamali, Moulay A ^b   Soares, Fernando Augusto ^d   Carraro, Dirce Maria ^a   Brentani, Helena Paula ^a   Hier, Michael ^c   Rogatto, Silvia Regina ^e   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

clinical outcome; epithelial mesenchymal transition; metastasis; oral squamous cell carcinoma; Twist

Indexed keywords

TUMOR MARKER; TWIST RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METASTASIS; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR MICROENVIRONMENT; TWIST RELATED PROTEIN 1 GENE; UPREGULATION;

CLINICAL OUTCOME; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS; ORAL SQUAMOUS CELL CARCINOMA; TWIST;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PROGNOSIS; TWIST TRANSCRIPTION FACTOR;

EID: 84892931229     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28404     Document Type: Article

References (37)

1. Su HH, Chu ST, Hou YY, et al. Spindle cell carcinoma of the oral cavity and oropharynx: factors affecting outcome. J Chin Med Assoc. 2006; 69: 478-483.
2. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
3. Dutton JM, Graham SM, Hoffman HT,. Metastatic cancer to the floor of mouth: the lingual lymph nodes. Head Neck. 2002; 24: 401-405.
4. Howell GM, Grandis JR,. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck. 2005; 27: 710-717.
5. Cavallaro U, Christofori G,. Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann N Y Acad Sci. 2004; 1014: 58-66.
6. Thompson EW, Newgreen DF, Tarin D,. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005; 65: 5991-5995.
7. Larue L, Bellacosa A,. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005; 24: 7443-7454.
8. Boyer B, Valles AM, Edme N,. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000; 60: 1091-1099.
9. Chin D, Boyle GM, Kane AJ, et al. Invasion and metastasis markers in cancers. Br J Plast Surg. 2005; 58: 466-474.
10. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996; 56: 2488-2492.
11. Pimenta Amaral TM, da Silva Freire AR, et al. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol. 2004; 40: 780-786.
12. Ziober AF, Falls EM, Ziober BL,. The extracellular matrix in oral squamous cell carcinoma: friend or foe? Head Neck. 2006; 28: 740-749.
13. Wahi PN, Cohen B, Luthra UK, et al. Histological Typing of Oral and Oropharyngeal Tumours. Geneva, Switzerland: World Health Organization; 1971.
14. Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol. 2005; 54: 95-105.
15. Zhang B, Schmoyer D, Kirov S, et al. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies [serial online]. BMC Bioinformatics. 2004; 5: 16.
16. Sanborn JZ, Benz SC, Craft B, et al. The UCSC Cancer Genomics Browser: update 2011. Nucleic Acids Res. 2011; 39 (database issue): D951-D959, 2011.
17. Bustin SA, Beaulieu JF, Huggett J, et al. MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments [serial online]. BMC Mol Biol. 2010; 21: 74.
18. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes [serial online]. Genome Biol. 2002; 3: RESEARCH0034.
19. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR [serial online]. Nucleic Acids Res. 2001; 29: e45.
20. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4: 844-847.
21. Tomizawa Y, Wu TT, Wang KK,. Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus. Oncol Lett. 2012; 3: 1059-1063.
22. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 2002; 21: 2634-2640.
23. Balys R, Alaoui-Jamali M, Hier M, et al. Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment. J Otolaryngol. 2006; 35: 157-166.
24. Mlynarek AM, Balys RL, Su J, et al. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2007; 133: 910-918.
25. Xu Y, Bismar TA, Su J, et al. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med. 2010; 207: 2421-2437.
26. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B, et al. Update on molecular pathology in oral cancer and precancer. Anticancer Res. 2008; 28: 1197-1205.
27. Ziober AF, Patel KR, Alawi F, et al. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res. 2006; 12: 5960-5971.
28. Thiery JP, Sleeman JP,. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7: 131-142.
29. Qin Q, Xu Y, He T, et al. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2012; 22: 90-106.
30. Franco HL, Casasnovas J, Rodriguez-Medina JR, et al. Redundant or separate entities?-roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res. 2011; 39: 1177-1186.
31. Alami J, Williams BR, Yeger H,. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours. Mol Pathol. 2003; 56: 218-225.
32. Ansieau S, Morel AP, Hinkal G, et al. TWISTing an embryonic transcription factor into an oncoprotein. Oncogene. 2010; 29: 3173-3184.
33. Yang WH, Lan HY, Huang CH, et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol. 2012; 14: 366-374.
34. Medici D, Hay ED, Olsen BR,. Snail and Slug promote epithelial- mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell. 2008; 19: 4875-4887.
35. Secchiero P, Bosco R, Celeghini C, et al. Recent advances in the therapeutic perspectives of Nutlin-3. Curr Pharm Des. 2011; 17: 569-577.
36. Whitesell L, Lindquist S,. Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin Ther Targets. 2009; 13: 469-478.
37. Fontan L, Yang C, Kabaleeswaran V, et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 2012; 22: 812-824.